Hawaii expects to restart J&J COVID vaccine soon
The state Department of Health expects to resume use of the Johnson & Johnson COVID-19 vaccine soon, nearly two weeks after federal agencies put a stop to the shot.
The Centers for Disease Control and Prevention and the Food and Drug Administration recommended a pause for the vaccine on April 13 after six individuals in the U.S. who received the vaccine developed a rare blood clot. Since then, nine other cases have been reported.
However, “following a thorough safety review, including two meetings of the CDC’s Advisory Committee on Immunization Practices,” the FDA and CDC decided that the pause “should be lifted and use of the vaccine should resume,” the two agencies said in a joint statement on Friday. They said that the vaccine is safe and effective and that the benefits outweigh the risk.
Hawaii’s Health Department said Friday that the screening form for people who choose to receive the vaccine and the FDA’s emergency use authorization are being updated. Once this happens, the department will restart use of the vaccines in Hawaii.
“The Johnson & Johnson vaccine continues to be another valuable tool in the fight against COVID-19,” DOH said Friday. “Those who do not want to wait for a Johnson & Johnson vaccine are encouraged to schedule a vaccine appointment for one of the other vaccine products as soon as possible.”
For more information, visit hawaiicovid19.com/ vaccination-registration/.